Medtronic's Hugo surgical robot gained FDA clearance for urologic procedures, opening U.S. market entry and setting the stage ...
Medtronic (NYSE: MDT) announced today that the FDA cleared its Hugo robotic-assisted surgery system for use in urologic surgical procedures.
With the U.S. authorization for urologic procedures, “there is now choice” for hospitals that want to expand their robotic ...
In both single-specialty urology and multi-specialty ASCs, longer, more complex procedures can be a good fit and good for profitability. The key for either type of facility is having a dedicated ...
Zacks Investment Research on MSN
MDT stock set to benefit from the FDA clearance of Hugo RAS system
Medtronic plc MDT has secured FDA approval for the Hugo robotic-assisted surgery (RAS) system for use in urologic surgical procedures. The clearance provides U.S. surgeons and the health system with a ...
With FDA clearance, the Hugo RAS system is indicated for use in minimally invasive urologic surgical procedures including prostatectomy, nephrectomy, and cystectomy — common procedures that account ...
Research published in the Journal of Urology suggests later operative start times — commonly thought to cause surgeon fatigue — may not necessarily lead to worse patient outcomes. For the study, ...
Only a minority of end-stage prostate cancer (PCa) patients undergo urologic procedures during their final three years of life, according to the first population-based study of its kind. David F.
A study published in JAMA Network Open examined the use of antibiotics among patients undergoing common urological procedures. Iowa City-based University of Iowa Health Care researchers manually ...
Cystoscopy was the most common procedure performed among all other urology endoscopy procedures in 2009, says the analyst of the research. However, it was the rigid cytoscope segment that generated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results